Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd5e8b1259c9db4154925eb3ef95e143 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-26 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-12 |
filingDate |
1999-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2003-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a31dcd2cd97c6ea3aabf659fedaba73a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a3f2fa764af6df742a5b196e135d520 |
publicationDate |
2003-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1095032-B1 |
titleOfInvention |
Reagents for cyp2d fluorescent assay |
abstract |
Novel fluorescent substrates of the human P450 enzyme CYP2D6 are provided. Also provided are methods for their manufacture and use. These substrates are useful in assessing CYP2D6 enzyme activity and in selecting compounds which inhibit CYP2D6 enzyme activity and, in particular, for identifying potential adverse drug interactions which are mediated by inhibition of CYP2D6 enzyme activity. |
priorityDate |
1998-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |